Persistent Negative Symptoms in Schizophrenia: An Overview

di Buchanan, Robert W.
Pubblicazione 2007

William T. Carpenter Jr: 35 Years of Clinical Trials

di Buchanan, Robert W.
Pubblicazione 2014

Early Intervention: How Early and With What?

di Carpenter, William T., Buchanan, Robert W.
Pubblicato in Schizophr Bull (2015)

Negative Symptom Therapeutics

di Carpenter, William T., Buchanan, Robert W.
Pubblicato in Schizophr Bull (2017)

Clinically Meaningful Gaps Between Clinical Trials and Patient Treatment

di Buchanan, Robert W, Carpenter, William T
Pubblicato in Schizophr Bull (2018)

Antipsychotic Medications: Flawed Concepts and Ethics

di Carpenter, William T, Buchanan, Robert W
Pubblicato in Schizophr Bull (2020)

Fast facts : esquizofrenia /

di Lewis, Shôn., Buchanan, Robert W.
Pubblicazione 2012.

A Case of Complete Omphalocele

di Buchanan, Robert W., Cain, Waldo L.
Pubblicazione 1956

Celebrating the Work of William T. Carpenter Jr

di Lehman, Anthony F., Buchanan, Robert W.
Pubblicazione 2014

Review of Clinical Correlates of P50 Sensory Gating Abnormalities in Patients with Schizophrenia

di Potter, David, Summerfelt, Ann, Gold, James, Buchanan, Robert W.
Pubblicazione 2006

The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trials

di Prentice, Kristen J., Gold, James M., Buchanan, Robert W.
Pubblicazione 2007

The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009

di Kreyenbuhl, Julie, Buchanan, Robert W., Dickerson, Faith B., Dixon, Lisa B.
Pubblicazione 2010

Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models

di Ahmed, Anthony O., Strauss, Gregory P., Buchanan, Robert W., Kirkpatrick, Brian, Carpenter, William T.
Pubblicato in Schizophr Bull (2015)

Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia

di Buchanan, Robert W., Freedman, Robert, Javitt, Daniel C., Abi-Dargham, Anissa, Lieberman, Jeffrey A.
Pubblicazione 2007

Nicotine Effects on Cognitive Remediation Training Outcome in People with Schizophrenia: a Pilot Study

di Hahn, Britta, Shrieves, Megan E., Yuille, Marie B., Buchanan, Robert W., Wells, Ashleigh K.
Pubblicato in Psychiatry Res (2019)

Intranasal oxytocin enhances EEG mu rhythm desynchronization during execution and observation of social action: An exploratory study

di Festante, Fabrizia, Ferrari, Pier Francesco, Thorpe, Samuel G., Buchanan, Robert W., Fox, Nathan A.
Pubblicato in Psychoneuroendocrinology (2019)

Neuropsychology of the Deficit Syndrome: New Data and Meta-analysis of Findings To Date

di Cohen, Alex S., Saperstein, Alice M., Gold, James M., Kirkpatrick, Brian, Carpenter, William T., Buchanan, Robert W.
Pubblicazione 2007

DIFFERENTIAL PATTERNS OF PREMORBID SOCIAL AND ACADEMIC DETERIORATION IN DEFICIT AND NONDEFICIT SCHIZOPHRENIA

di Strauss, Gregory P., Allen, Daniel N., Miski, Pinar, Buchanan, Robert W., Kirkpatrick, Brian, Carpenter, William T.
Pubblicazione 2011

The Practice Research Network: A Collaboration Between the University of Maryland and the Public Mental Health System

di Sundeen, Sandra J., Goldman, Howard H., Nieberding, Daniel J., Piez, Deborah A., Buchanan, Robert W.
Pubblicazione 2013

Effects of a nicotinic agonist on the Brief Psychiatric Rating Scale five-factor subscale model in schizophrenia

di Lewis, Alan S., Olincy, Ann, Buchanan, Robert W., Kem, William R., Picciotto, Marina R., Freedman, Robert
Pubblicato in Schizophr Res (2017)